bpc-157 recommended dosage cycle length Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Guide: Safety, Cycles,
Description
Nat Genet
Am J Physiol 225: 11071113, 1973

Do not change the schedule without medical advice
Compounds that disrupt glucose-insulin dynamics typically create hunger patterns that interfere with dietary adherence

Having witnessed the profound impact of B12 on energy and neurological function, I am passionate about providing evidence-based clarity on what recovery actually looks like.
